Company profile

Virtual Incision

Surgical AI & Robotics

Company profile

About Virtual Incision

Virtual Incision is on a mission to miniaturize robotic surgery, making robotic-assisted surgery (RAS) more accessible to patients, surgeons, and healthcare facilities. The company has developed MIRA, the world's first Miniaturized Robotic-Assisted Surgery (miniRAS) system, which represents a significant departure from traditional mainframe robotic surgery systems. MIRA's compact, tray-to-table design aims to accelerate the adoption of RAS by fitting within existing hospital infrastructure, either as a complement to mainframe systems or as a stand-alone solution. The system enables surgery to be performed with precision through small incisions, potentially resulting in low conversions to open surgery, short hospital stays, and reduced complications. Virtual Incision addresses a critical access problem in robotic surgery: the complexity of mainframe RAS systems limits how many surgeries can be performed, leaving millions of patients without access to these benefits. By miniaturizing the technology, Virtual Incision seeks to enable more surgeries per day, allowing more patients to benefit from robotic-assisted procedures. The company has successfully completed procedures including hysterectomies with the MIRA system and has demonstrated remote robotic-assisted surgery capabilities through collaborations with partners including Sovato, City of Hope, and University of Illinois Chicago. Virtual Incision is exploring advanced technologies including NVIDIA Isaac for Healthcare to enhance its surgical robotics capabilities.

Company description Virtual Incision official website

Primary marketSurgical AI & Robotics
Commercial modelCommercial information available on request
Company presenceLinkedIn X
Work at Virtual Incision?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • general surgery
  • gynecological surgery
  • hysterectomy

Who it serves

  • Health Systems
  • Hospitals
  • Surgical Centers

Deployment & integration

On Premise deployment with recorded integration context.

Geographic context

MarketsUnited States
Company sourceOfficial website

Company milestones

Platform expansion

Jim Alecxih appointed as CEO (June 2025). First hysterectomy completed with MIRA system (July 2024). Remote robotic-assisted surgery demonstration completed (November 2024). Exploring NVIDIA Isaac for Healthcare integration (March 2025).

Partnerships

Recorded partners

  • City of Hope
  • NVIDIA
  • Sovato
  • University of Illinois Chicago

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

MIRA Surgical System

World's first Miniaturized Robotic-Assisted Surgery (miniRAS) system

Device · On PremiseCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

Low conversions to open surgery

Robotic-assisted surgery with MIRA system

Short hospital stays

Minimally invasive surgery through small incisions

Reduced complications

Precision surgery enabled by robotic assistance

City of Hope and University of Illinois Chicago (with Sovato)

U.S.-based remote robotic-assisted surgery demonstration

Successfully completed remote robotic-assisted surgery demonstration

Undisclosed healthcare facility

First hysterectomy performed with MIRA Surgical System

Successful completion of first hysterectomy procedure with MIRA

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Jim Alecxih

Jim Alecxih

President & Chief Executive Officer

LinkedIn

Florence Beck

VP Clinical & Regulatory Affairs

LinkedIn

06 · Company updates

Updates from Virtual Incision

Recent articles published on Virtual Incision's official website.

No Company updates are currently listed.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Surgical AI & Robotics

Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon